We are monitoring the impact of COVID-19 & Recession alarm on MEA Cancer Biomarkers Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Cancer Biomarkers Market Research Report – Segmented By Disease, Services, Application, Type, Profiling Technologies, Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 2151
Pages: 145

MEA Cancer Biomarkers Market Size (2022 to 2027)

The size of the Cancer Biomarkers Market in the Middle East & Africa was worth USD 1.15 billion in 2022 and estimated to be growing at a CAGR of 11.652% to reach USD 2.00 billion by 2027.

Biomarkers are used in imaging technology to offer precise imaging of oncology tumors and other problems and also eradicate the possibility of radiation exposure during imaging through CT scans and MRI scans. In addition, biomarkers facilitate pharmaceutical companies to analyze and discover novel drugs as demand for valuable and efficient treatment doses increases.

The cancer biomarkers market is expected to witness lucrative growth over the forecast period owing to the rising prevalence of cancer, improper diet, increasing consumption of tobacco, lack of physical activities, and many sun & UV exposures. Furthermore, the growing geriatric population base, raising awareness regarding the usage of biomarkers at various stages of cancers, and rising demand for clinical diagnosis in the early stages of cancers are some factors that are expected to boost usage rates.

The high cost of diagnostic procedures is restraining market growth.

This research report on the MEA Cancer Biomarkers Market segmented and sub-segmented into the following categories:

By Disease: 

  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Other Cancers

By Services: 

  • Sample Preparation
  • Assay Development
  • Biomarkers Validation
  • Testing

By Application: 

  • Risk Assessment
  • Development of Molecular Diagnostics
  • Disease Diagnosis
  • Drug Discovery & Development
  • Drug Formulation

By Type: 

  • Protein Biomarkers
  • Genetic Biomarkers
  • Other Biomarkers

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

KEY MARKET PLAYERS:

Some of the prominent companies operating in the Middle East & Africa cancer biomarkers market profiled in this report are Abbott Laboratories, Agendia Bv, Biocurex Inc, Biomerieux S.A, Biomoda Inc., Astellas Pharma Us Inc., Correlogic Systems Inc., Beckman Coulter Inc., Becton, Dickinson and Company, Clarient Inc., Diadexus Inc., Ambrilia Biopharma, Affymetrix Inc and Aureon Laboratories Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Disease                        

                                5.1.1 Introduction           

                                5.1.2 Prostate Cancer    

                                5.1.3 Breast Cancer        

                                5.1.4 Lung Cancer            

                                5.1.5 Colorectal Cancer 

                                5.1.6 Cervical Cancer      

                                5.1.7 Other Cancers       

                                5.1.8  Y-o-Y Growth Analysis, By Disease               

                                5.1.9  Market Attractiveness Analysis, By Disease             

                                5.1.10  Market Share Analysis, By Disease            

                5.2 Services                       

                                5.2.1 Introduction           

                                5.2.2 Sample Preparation            

                                5.2.3 Assay development            

                                5.2.4 Biomarkers validation and testing 

                                5.2.5  Y-o-Y Growth Analysis, By Services              

                                5.2.6  Market Attractiveness Analysis, By Services            

                                5.2.7  Market Share Analysis, By Services             

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Risk Assessment   

                                5.3.3 Development of molecular diagnostics       

                                5.3.4 Disease diagnosis 

                                5.3.5 Drug discovery      

                                5.3.6 Development and Drug formulation            

                                5.3.7  Y-o-Y Growth Analysis, By Application        

                                5.3.8  Market Attractiveness Analysis, By Application      

                                5.3.9  Market Share Analysis, By Application       

                5.4 Type                              

                                5.4.1 Introduction           

                                5.4.2 Protein Biomarkers             

                                5.4.3 Genetic biomarkers            

                                5.4.4 genetic biomarkers             

                                5.4.7  Y-o-Y Growth Analysis, By Type    

                                5.4.8  Market Attractiveness Analysis, By Type  

                                5.4.9  Market Share Analysis, By Type    

                5.5 Profiling Technologies                            

                                5.5.1 Omics technologies             

                                                5.5.1.1 Genomics

                                                5.5.1.2 Proteomics

                                                5.5.1.3 Metabolomics

                                                5.5.1.4 Transcriptomics

                                                5.5.1.5 Pharmacogenomics

                                5.5.2 Imaging technologies         

                                5.5.3 Immunoassays      

                                5.5.4 Cytogenetics          

                                5.5.5 Bioinformatics       

                                5.5.6 IVD multivariate index assays         

                                5.5.7  Y-o-Y Growth Analysis, By Profiling Technologies  

                                5.5.8  Market Attractiveness Analysis, By Profiling Technologies                

                                5.5.9  Market Share Analysis, By Profiling Technologies  

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Disease

                                                6.1.3.3 By Services

                                                6.1.3.4 By Application

                                                6.1.3.5 By Type

                                                6.1.3.6 Profiling Technologies

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Disease

                                                6.1.4.3 By Services

                                                6.1.4.4 By Application

                                                6.1.4.5 By Type

                                                6.1.4.6 Profiling Technologies

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Disease

                                                6.1.5.3 By Services

                                                6.1.5.4 By Application

                                                6.1.5.5 By Type

                                                6.1.5.6 Profiling Technologies

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Abbott Laboratories                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Agendia Bv                 

                8.3 Biocurex Inc                               

                8.4 Biomerieux S.A.                        

                8.5 Biomoda Inc                               

                8.6 Astellas Pharma Us Inc                          

                8.7 Correlogic Systems Inc                           

                8.8 Beckman Coulter Inc                              

                8.9 Becton                          

                8.10 Dickinson And Company                     

                8.11 Clarient Inc                               

                8.12 Diadexus Inc                            

                8.13 Ambrilia Biopharma                              

                8.14 Affymetrix Inc                         

                8.15 Aureon Laboratories Inc.                    

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Middle East & Africa Cancer Biomarkers Market, By Disease, From 2022 - 2027 (USD Million)
  2. Middle East & Africa Prostate Cancer Market, By Region, From 2022 - 2027 (USD Million)
  3. Middle East & Africa Breast Cancer Market, By Region, From 2022 - 2027 (USD Million)
  4. Middle East & Africa Lung Cancer Market, By Region, From 2022 - 2027 (USD Million)
  5. Middle East & Africa Colorectal Cancer Market, By Region, From 2022 - 2027 (USD Million)
  6. Middle East & Africa Cervical Cancer  Market, By Region, From 2022 - 2027 (USD Million)
  7. Middle East & Africa Other Cancers Market, By Region, From 2022 - 2027 (USD Million)
  8. Middle East & Africa Cancer Biomarkers Market, By Services, From 2022 - 2027 (USD Million)
  9. Middle East & Africa Sample Preparation Market, By Region, From 2022 - 2027 (USD Million)
  10. Middle East & Africa Assay development  Market, By Region, From 2022 - 2027 (USD Million)
  11. Middle East & Africa Biomarkers validation and testing Market, By Region, From 2022 - 2027 (USD Million)
  12. Middle East & Africa Cancer Biomarkers Market, By Application, From 2022 - 2027 (USD Million)
  13. Middle East & Africa Risk Assessment Market, By Region, From 2022 - 2027 (USD Million)
  14. Middle East & Africa Development of molecular diagnostics Market, By Region, From 2022 - 2027 (USD Million)
  15. Middle East & Africa Disease diagnosis Market, By Region, From 2022 - 2027 (USD Million)
  16. Middle East & Africa Drug discovery  Market, By Region, From 2022 - 2027 (USD Million)
  17. Middle East & Africa Development and Drug formulation Market, By Region, From 2022 - 2027 (USD Million)
  18. Middle East & Africa Cancer Biomarkers Market, By Type, From 2022 - 2027 (USD Million)
  19. Middle East & Africa Protein Biomarkers Market, By Region, From 2022 - 2027 (USD Million)
  20. Middle East & Africa Genetic biomarkers  Market, By Region, From 2022 - 2027 (USD Million)
  21. Middle East & Africa Other biomarkers Market, By Region, From 2022 - 2027 (USD Million)
  22. Middle East & Africa Cancer Biomarkers Market, By Profiling Technologies , From 2022 - 2027 (USD Million)
  23. Middle East & Africa Omics technologies  Market, By Region, From 2022 - 2027 (USD Million)
  24. Middle East & Africa Imaging technologies Market, By Region, From 2022 - 2027 (USD Million)
  25. Middle East & Africa Immunoassays Market, By Region, From 2022 - 2027 (USD Million)
  26. Middle East & Africa Cytogenetics Market, By Region, From 2022 - 2027 (USD Million)
  27. Middle East & Africa Bioinformatics Market, By Region, From 2022 - 2027 (USD Million)
  28. Middle East & Africa IVD multivariate index assays Market, By Region, From 2022 - 2027 (USD Million)
  29. Middle East Cancer Biomarkers Market, By Disease, From 2022 - 2027 (USD Million)
  30. Middle East Cancer Biomarkers Market, By Services, From 2022 - 2027 (USD Million)
  31. Middle East Cancer Biomarkers Market, By Application, From 2022 - 2027 (USD Million)
  32. Middle East Cancer Biomarkers Market, By Type, From 2022 - 2027 (USD Million)
  33. Middle East Cancer Biomarkers Market, By Profiling Technologies , From 2022 - 2027 (USD Million)
  34. Africa Cancer Biomarkers Market, By Disease, From 2022 - 2027 (USD Million)
  35. Africa Cancer Biomarkers Market, By Services, From 2022 - 2027 (USD Million)
  36. Africa Cancer Biomarkers Market, By Application, From 2022 - 2027 (USD Million)
  37. Africa Cancer Biomarkers Market, By Type, From 2022 - 2027 (USD Million)
  38. Africa Cancer Biomarkers Market, By Profiling Technologies , From 2022 - 2027 (USD Million)
  39. Middle East & Africa Cancer Biomarkers Market, By Omics technologies , From 2022 - 2027 (USD Million)
  40. Middle East & Africa Genomics Market, By Region, From 2022 - 2027 (USD Million)
  41. Middle East & Africa Proteomics Market, By Region, From 2022 - 2027 (USD Million)
  42. Middle East & Africa Metabolomics Market, By Region, From 2022 - 2027 (USD Million)
  43. Middle East & Africa Transcriptomics Market, By Region, From 2022 - 2027 (USD Million)
  44. Middle East & Africa Pharmacogenomics Market, By Region, From 2022 - 2027 (USD Million)
  45. Middle East Cancer Biomarkers Market, By Omics technologies , From 2022 - 2027 (USD Million)
  46. Africa Cancer Biomarkers Market, By Omics technologies , From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample